check_circleStudy Completed
Hypogonadism
Bayer Identifier:
13899
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Efficacy and tolerability of Testogel/Nebido in combination with exercise and diet in hypogonadal male patients
Trial purpose
With advancing age testosterone levels decline in men. Low testosterone levels plus certain symptoms are called "Late Onset Hypogonadism (LOH)". Adipose tissue may contribute to testosterone deficiency. On the other hand testosterone deficiency again leads to a decrease in lean body mass and an increase in fat mass - one of the clinical signs / symptoms of LOH. Lifestyle changes (diet, exercise) alone or in combination with testosterone replacement (TRT), have an influence on the symptoms of LOH. The aim of this study is to assess the additional impact of TRT on Aging Male Symptom Score (AMS) and adiposity (waist circumference) in patients, who are on a diet and exercise program.
Key Participants Requirements
Sex
MaleAge
35 - 64 YearsTrial summary
Enrollment Goal
30Trial Dates
June 2007 - October 2008Phase
N/ACould I Receive a placebo
NoProducts
Nebido (Testosterone Undeconate, BAY86-5037)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many locations, Germany |
Primary Outcome
- Waist Circumferencedate_rangeTime Frame:At each visitenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A